Garlic kills cancer cells
Scientists have destroyed malignant tumours in mice using chemical that occurs in garlic.Updated: Dec 31, 2003 23:07 IST
A team of Israeli scientists have destroyed malignant tumours in mice using a chemical that occurs naturally in garlic.
The key to the scientists' success lies in the development of a unique, two-step system for delivering the cancer-wrecking chemical straight to the tumour cells.
Allicin, as the chemical is called, is the substance that gives garlic its distinctive aroma and flavour. For many years, scientists studying allicin have known that it is as toxic as it is pungent. It has been shown to kill not only cancer cells, but the cells of disease-causing microbes, and even healthy human body cells.
Fortunately for our body's cells, Allicin is highly unstable, and breaks down quickly once ingested. However, the rapid breakdown and undiscriminating toxicity presented twin hurdles to creating an Allicin-based therapy.
At the Weizmann Institute's Biological Chemistry Department, a team of doctors have solved both these problems by designing an ingenious delivery method that works with the pinpoint accuracy of a smart bomb. Their findings were reported in the December issue of Molecular Cancer Therapeutics.
The method parallels the way Allicin is synthesized in nature. Not present in whole, unbroken cloves of garlic, Allicin is the product of a biochemical reaction between two substances stored apart in tiny, adjoining compartments within each clove.
The two are an enzyme, Alliinase, and a normally inert chemical called Alliin. When the clove is damaged, whether by soil parasites intending to eat the tender tissues, or by cooks making sauce, the membranes separating the compartments are ruptured and rapid allicin production follows.
The scientists realized that if doses of allicin could be repeatedly generated in this way at the site of the tumour, the highest concentration of the toxic molecules would be available for killing cancer cells.
To zero in on the targeted tumour, scientists took advantage of the fact that most types of cancer cells exhibit distinctive receptors on their surfaces. An antibody that is "programmed" to recognize the tumour's characteristic receptor is chemically bound to the enzyme, Alliinase. Injected into the bloodstream, the antibody seeks out these cells, and lodges itself and its passenger enzyme on the tumour cells.
The scientists then inject the second component, Alliin, at intervals. When it encounters the Alliinase, the resulting reaction turns the normally inert Alliin molecules into lethal Allicin molecules, which penetrate and kill the tumor cells. Due to the precise delivery system, neighboring, healthy cells remain intact.
Using this method, the team succeeded in blocking the growth of gastric tumoUUUrs in mice. The tumoUr-inhibiting effects were seen up to the end of the experimental period, long after the internally produced Allicin was spent.
The scientists note that the method could work for most types of cancer, as long as a specific antibody can be customized to recognize receptors unique to the cancer cells.
First Published: Dec 31, 2003 23:07 IST